Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States

Background Studies evaluating insurance status and melanoma outcomes are limited. Objective We investigated whether health insurance correlates with more advanced disease, receipt of treatment, and survival in melanoma. Methods This was a cross-sectional analysis of 61,650 patients with cutaneous me...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2016-02, Vol.74 (2), p.309-316
Main Authors: Amini, Arya, MD, Rusthoven, Chad G., MD, Waxweiler, Timothy V., MD, Jones, Bernard L., PhD, Fisher, Christine M., MD, MPH, Karam, Sana D., MD, PhD, Raben, David, MD
Format: Article
Language:English
Subjects:
Adult
Affordable Care Act
Cross-Sectional Studies
Dermatology
Female
health care disparities
health insurance
Humans
Insurance, Health - statistics & numerical data
Kaplan-Meier Estimate
Male
malignant melanoma
Medicaid - statistics & numerical data
Medically Uninsured - statistics & numerical data
Melanoma - mortality
Melanoma - pathology
Melanoma - therapy
Middle Aged
Neoplasm Staging
Retrospective Studies
SEER Program
Skin Neoplasms - mortality
Skin Neoplasms - pathology
Skin Neoplasms - therapy
Skin Ulcer - epidemiology
Skin Ulcer - etiology
Survival Rate
treatment outcomes
United States - epidemiology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Studies evaluating insurance status and melanoma outcomes are limited. Objective We investigated whether health insurance correlates with more advanced disease, receipt of treatment, and survival in melanoma. Methods This was a cross-sectional analysis of 61,650 patients with cutaneous melanoma using the Surveillance, Epidemiology, and End Results database. Results Under multivariate analysis, patients with either Medicaid insurance (hazard ratio, 1.83; 95% confidence interval [CI], 1.65-2.04; P  
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2015.09.054